Literature DB >> 23994893

Important cytotoxicity of novel iron(II) cyclopentadienyl complexes with imidazole based ligands.

Ana Cristina Gonçalves1, Tânia S Morais, M Paula Robalo, Fernanda Marques, Fernando Avecilla, Cristina P Matos, Isabel Santos, Ana Isabel Tomaz, M Helena Garcia.   

Abstract

Four new compounds of general formula [FeCp(dppe)L][CF3SO3] with L=imidazole substituted ligands, and dppe=ethylenebis(diphenylphosphane) have been synthesized and characterized with the aim to evaluate their anticancer properties. The new compounds were fully characterized by spectroscopic and electrochemical methods and the structure of [Fe(η(5)-C5H5)(dppe)(1-BuIm)] [CF3SO3] (1), [Fe(η(5)-C5H5)(dppe) (ImH)][CF3SO3] (3) and [Fe(η(5)-C5H5)(dppe)(1HmIm)][CF3SO3] (4) (where 1-BuIm=1-butylimidazole, and 1HmIm=N-hydroxymethylimidazole) was determined by X-ray diffraction studies. Apparently, these compounds are the first reported 'Fe(η(5)-C5H5)' half sandwich derivatives presenting high cytotoxic activity against a set a human tumor cell lines predicting their potential value as antitumor drugs.
© 2013.

Entities:  

Keywords:  Cyclopentadienyl; Cytotoxicity; Heteroaromatic ligands; Iron; Organometallic; X-ray structure

Mesh:

Substances:

Year:  2013        PMID: 23994893     DOI: 10.1016/j.jinorgbio.2013.07.033

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

Review 1.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

2.  A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity Against Colorectal and Triple Negative Breast Cancer Cells.

Authors:  Adhan Pilon; Ana Rita Brás; Leonor Côrte-Real; Fernando Avecilla; Paulo J Costa; Ana Preto; M Helena Garcia; Andreia Valente
Journal:  Molecules       Date:  2020-03-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.